Multiple levers are available to improve public health
Business Standard brings you the top headlines at this hour
A senior official of the WHO has urged countries to take science-based precautionary Covid-19 entry restrictions that are proportionate and non-discriminatory
The director of the World Health Organisation's Europe office said Tuesday that the agency sees no immediate threat" for the European region from a COVID-19 outbreak in China, but more information is needed. China is battling a nationwide outbreak of the coronavirus after abruptly easing restrictions. Hans Kluge said that, based on the information WHO had received from china, there was no threat, but more detailed and regular information was required from China to monitor the evolving situation. We cannot be complacent, he added. Several countries have imposed COVID-19 testing requirements on Chinese travellers. Australia and Canada require travellers from China to take a COVID-19 test prior to boarding their flight. Other countries including the U.S., India, Japan, South Korea and several European nations have announced tougher COVID-19 measures on travellers from China amid concerns over a lack of data on infections in China and fears that new variants may emerge. China has thr
Facts have proved that we have always maintained close communication and shared relevant information and data with WHO in a timely manner: China
Chinese health officials have said only deaths caused by pneumonia and respiratory failure in patients who had the virus are classified as Covid deaths
The World Health Organization (WHO) warned that China is "under-representing the true impact" of the Covid-19 pandemic in the country, especially the exact number of deaths.
The organization further said that a few other Omicron sublineages were also detected, albeit in low percentages in China; presently, no new variants of the coronavirus have been found
The World Health Organization has again urged China to regularly share specific and real-time data on the COVID-19 situation in the country, amid a surge in coronavirus cases after Beijing relaxed its strict "zero-COVID" policy. The global health agency has asked Chinese health officials to share data on genetic sequencing, hospitalisations, deaths and vaccinations. A high-level meeting took place between officials from WHO and China on the current surge in COVID-19 cases to seek further information on the situation, and to offer WHO's expertise and further support, a WHO statement said on Friday. WHO again asked for regular sharing of specific and real-time data on the epidemiological situation including more genetic sequencing data, data on disease impact including hospitalisations, ICU admissions and deaths and data on vaccinations delivered and vaccination status, especially in vulnerable people and those over 60 years old, it added. WHO reiterated the importance of vaccinatio
Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis
Hetero, a city-based leading pharmaceutical company on Monday announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of COVID-19 oral anti-viral treatment candidate Nirmatrelvir. A press release from the drug maker said it is the first prequalification for a generic version of Pfizer's COVID-19 oral anti-viral drug 'Paxlovid,' which the WHO called, the best therapeutic choice for high-risk patients to date. WHO made a strong recommendation for Nirmatrelvir and Ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission, such as unvaccinated, aged or immunosuppressed patients, it said. The combi pack, launched by Hetero as Nirmacom, will contain Nirmatrelvir 150 mg (2 tablets) and Ritonavir 100mg (1 tablet). It is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset. Nirmacom will be ...
Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products, stating that they failed to comply with the World Health Organisation's (WHO) drug manufacturing standards. The Department of Drug Administration, in a notice issued on December 18 asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. According to the notice issued by the Department, the medicines manufactured by the listed companies cannot be imported or distributed in Nepal. The list of the companies that do not comply with WHO standards were published after inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal, according to the Department officials. In April and July, the Department sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that
Health ministry sources say no immediate plan to allow plant to re-open, it was closed for non-compliance with GMP, not for contamination issues
Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"
Catch all the latest news from around the world here
World Health Organization (WHO) head Tedros Adhanom Ghebreyesus on Wednesday called on China to share the requested data concerning Covid-19 in a bid to understand the origins of the virus
Madhya Pradesh's capital Bhopal is called the 'city of lakes', for which, the World Health Organization (WHO) has started preparations to make it a 'healthy city'.
Countries with lower rates of testing, mostly low- and middle-income countries, are more likely to report significantly higher AMR rates
Although the level of COVID-19 infections across the African continent is at its lowest since the start of the pandemic two years ago, a recent four-week sustained increase calls for maintaining vigilance as the year-end holiday season sets in, the World Health Organization's Africa director has said. Despite the recent uptick, there is hope that Africa will be spared the challenges of the previous two years, when surging cases and deaths withered normal life and caused deep devastation. While the current trends keep the pandemic under control, we are carefully monitoring its evolution, said Dr Matshidiso Moeti, WHO Regional Director for Africa at an online media briefing Thursday. The investments made in the COVID-19 fight over the last three years were paying off, with the region better able to cope with the virus and its health emergency response systems bolstered, he said. We must remain vigilant, continue to increase vaccination coverage and be ready to adopt more stringent ..
The global number of malaria cases and deaths generally remained stable in 2021, thanks to redoubled efforts by affected countries, the WHO said